Boston Biomedical Associates Broadens its Portfolio with a Focus on Strategic Technology Development as Stefan Schreck, PhD Joins the Senior Management Team

Loading media player...

Innovation - Part 1 Dr. Stefan Schreck, Boston Biomedical Associates

???pagination.previous??? ???pagination.next???

MARLBOROUGH, Mass.--()--Boston Biomedical Associates (BBA) is proud to announce that Dr. Stefan Schreck has joined the management team as Executive Director, Science and Technology where he will provide domestic and international clients with pre-clinical strategic technology development assistance. Watch Stefan discuss his approach to engineering and solving design problems in a unique way.

“Dr. Schreck has an innate ability to help organizations speed up the process for regulatory engagement by facilitating effective discussions between the development teams, the product end users and regulators” noted BBA President and CEO Lauren Baker. “We are very fortunate to have someone of Stefan’s caliber join the BBA team and I know he will be an invaluable asset to our clients as they develop innovative medical treatment solutions,” she added.

“The global audience that BBA serves is a perfect opportunity for me to apply my 25 years of experience in developing and commercializing innovative medical products,” Dr. Schreck said. “I look forward to helping companies pro-actively manage the risks and opportunities of their unique technologies and focus on the key drivers toward a successful clinical outcome.”

From 1986 to 1993, Dr. Schreck conducted biomedical research at the University of Houston, Houston, TX, the Georgia Institute of Technology, Atlanta, GA, and the University of Southern California, Los Angeles, CA. Over the next 23 years, he held senior R&D positions at Pfizer and Edwards Lifesciences, and served as the Chief Technology Officer of Endologix and JenaValve. He also advised several med-tech startup companies and successfully secured federal grant funding.

Dr. Schreck earned his PhD in Mechanical Engineering from the University of Houston and his M.A. in Aerospace Engineering from the Technische Hochschule Munchen in Munich Germany.

In addition to being the inventor on more than 30 US patents, Dr. Schreck has published 13 scientific articles on a variety of topics associated with cardiac care and fatigue testing along with publications associated with the structure of the human nose.

To learn more about Dr. Schreck and his risk-based approach to medical product development visit www.boston-biomedical.com

ABOUT BOSTON BIOMEDICAL ASSOCIATES: Boston Biomedical Associates (BBA) serves as a strategic partner with clients involved in a variety of medical technologies and working with them throughout the entire medical product life cycle to facilitate bringing new products to market. BBA is also a leading Clinical Research Organization known for its comprehensive approach to facilitating the clinical trial operations process.

Follow BBA on Twitter https://twitter.com/BBA_CRO and Linkedin https://www.linkedin.com/company-beta/1312584/.

Contacts

Boston Biomedical Associates
Stephanie Cilibrasi, 508-691-7037
scilibrasi@boston-biomedical.com

Release Summary

Boston Biomedical Associates, a leading Clinical Research Organization, announces that Dr. Stefan Schreck has joined their management team as Executive Director, Science and Technology.

Contacts

Boston Biomedical Associates
Stephanie Cilibrasi, 508-691-7037
scilibrasi@boston-biomedical.com